MDS 的分子监测：关注这一领域！
Molecular monitoring of MDS: Watch this space!
机构信息
University of Cologne, Cologne, Germany.
出版信息
Br J Haematol. 2024 Sep;205(3):757-758. doi: 10.1111/bjh.19644. Epub 2024 Jul 22.
The use of IPSS-M provides a wealth of molecular information in newly diagnosed myelodysplastic syndromes (MDS) patients. Besides the prognostic implications, molecular markers will also help to choose therapeutic options and may also be informative to determine the depth of response. Duployez and Preudhomme provide a comprehensive overview of this area of research, which is particularly complex in MDS. Commentary on: Duployez et al. Monitoring molecular changes in the management of myelodysplastic syndromes. Br J Haematol 2024; 205:772-779.
IPSS-M 在新诊断的骨髓增生异常综合征 (MDS) 患者中提供了丰富的分子信息。除了预后意义外，分子标志物还有助于选择治疗方案，也可能有助于确定反应的深度。Duployez 和 Preudhomme 全面概述了 MDS 这一复杂领域的研究。评论：Duployez 等人。在骨髓增生异常综合征的治疗管理中监测分子变化。英国血液学杂志 2024;205:772-779。
Zotero 插件